Our research showed that high expression of LOXL3 was confirmed in GC of TCGA data by using UALCAN database, and the expression was correlated with tumor stage, while there was no difference in the results of Oncomine and GEPIA. The gene discussed is LOXL3; the disease is neoplasm.